Montelukast for kidney protection in type 2 diabetes
Treatments studied
Part of Eyes & vision, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a common asthma medication (montelukast) can help protect kidney, heart, and eye health in people with type 2 diabetes and early kidney problems. The study aims to see if the drug can slow down kidney damage and improve overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- Your kidney function is moderately reduced (called stage 2 or 3 kidney disease).
- You have a certain amount of protein in your urine, which shows your kidneys are under stress.
- Your blood pressure is controlled (under 140/90 mmHg), and you are taking a common blood pressure pill (ACE inhibitor or ARB) at a steady dose for at least 4 weeks.
- You are not pregnant or planning pregnancy, and you don't have major psychiatric conditions.
- You have not used certain steroids or long-acting asthma inhalers recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a medicine called an SGLT2 inhibitor (a type of diabetes drug) can help protect the kidneys and heart in people with chronic kidney disease or type 2 diabetes. If you have either condition, you might be able to join.
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
This trial tests whether montelukast, a medicine commonly used for allergies, can improve kidney health and blood vessel function in adults with long-term type 1 diabetes. You may join a treatment group and have kidney and circulation measurements taken over the study period.
This trial tests if a drug called formoterol (usually used for asthma) can help protect the kidneys in people with type 2 diabetes and early-to-moderate kidney disease. It may offer a new way to slow kidney damage.
This study tests whether adding a non-steroidal mineralocorticoid antagonist to your current type 2 diabetes and kidney disease medications (SGLT2i and ACEi/ARB) is cost-effective. It may help preserve kidney function and reduce heart risks.
This trial studies whether a low daily dose of aspirin can help protect kidney function in people with early diabetic nephropathy. It aims to slow down the progression of kidney damage.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.